Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 9 | 2023 | 306 | 1.880 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2016 | 137 | 1.820 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2016 | 325 | 1.500 |
Why?
|
| Sesquiterpenes | 3 | 2013 | 30 | 1.280 |
Why?
|
| Streptomyces | 3 | 2014 | 18 | 1.220 |
Why?
|
| Withanolides | 3 | 2016 | 8 | 1.170 |
Why?
|
| Anti-Bacterial Agents | 5 | 2018 | 355 | 1.150 |
Why?
|
| Plant Extracts | 10 | 2016 | 250 | 1.050 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 4 | 0.950 |
Why?
|
| Lactones | 2 | 2013 | 20 | 0.930 |
Why?
|
| Vernonia | 2 | 2013 | 15 | 0.920 |
Why?
|
| Molecular Structure | 13 | 2018 | 467 | 0.910 |
Why?
|
| Plants, Medicinal | 5 | 2010 | 54 | 0.880 |
Why?
|
| Lipopolysaccharides | 5 | 2023 | 200 | 0.860 |
Why?
|
| Nitric Oxide | 7 | 2016 | 287 | 0.840 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 12 | 0.730 |
Why?
|
| Physalis | 2 | 2016 | 3 | 0.720 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2018 | 203 | 0.600 |
Why?
|
| Gardenia | 1 | 2016 | 1 | 0.590 |
Why?
|
| Triterpenes | 1 | 2016 | 12 | 0.580 |
Why?
|
| Disaccharidases | 1 | 2016 | 1 | 0.580 |
Why?
|
| Levivirus | 1 | 2016 | 1 | 0.580 |
Why?
|
| Morinda | 1 | 2016 | 9 | 0.570 |
Why?
|
| Structure-Activity Relationship | 8 | 2018 | 376 | 0.570 |
Why?
|
| Indoles | 2 | 2014 | 154 | 0.550 |
Why?
|
| Chaetomium | 1 | 2015 | 2 | 0.550 |
Why?
|
| Benzopyrans | 1 | 2015 | 10 | 0.550 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 112 | 0.530 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 182 | 0.500 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 26 | 0.500 |
Why?
|
| Purine Nucleosides | 1 | 2014 | 14 | 0.490 |
Why?
|
| STAT3 Transcription Factor | 2 | 2015 | 80 | 0.490 |
Why?
|
| Peptide Fragments | 1 | 2016 | 298 | 0.490 |
Why?
|
| Moringa oleifera | 2 | 2011 | 2 | 0.480 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 147 | 0.480 |
Why?
|
| Carbazoles | 1 | 2014 | 43 | 0.480 |
Why?
|
| Mice | 12 | 2016 | 5668 | 0.480 |
Why?
|
| Sulfonamides | 1 | 2014 | 75 | 0.470 |
Why?
|
| Withania | 1 | 2013 | 4 | 0.460 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2013 | 107 | 0.450 |
Why?
|
| Cell Line | 5 | 2016 | 1289 | 0.390 |
Why?
|
| Aminocoumarins | 1 | 2010 | 1 | 0.380 |
Why?
|
| Novobiocin | 1 | 2010 | 2 | 0.380 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 58 | 0.380 |
Why?
|
| Porifera | 1 | 2010 | 8 | 0.380 |
Why?
|
| Glycosides | 1 | 2010 | 19 | 0.370 |
Why?
|
| Peroxides | 1 | 2010 | 20 | 0.370 |
Why?
|
| Macrophages | 2 | 2013 | 431 | 0.370 |
Why?
|
| Animals | 15 | 2023 | 14307 | 0.360 |
Why?
|
| Imides | 1 | 2009 | 9 | 0.360 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 27 | 0.360 |
Why?
|
| Phytotherapy | 2 | 2007 | 62 | 0.360 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2014 | 78 | 0.320 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 193 | 0.320 |
Why?
|
| Mycobacterium marinum | 1 | 2007 | 7 | 0.310 |
Why?
|
| Apoptosis | 3 | 2023 | 1317 | 0.310 |
Why?
|
| Models, Molecular | 3 | 2016 | 751 | 0.300 |
Why?
|
| Isothiocyanates | 4 | 2023 | 18 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 984 | 0.290 |
Why?
|
| Humans | 18 | 2023 | 34853 | 0.290 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2015 | 281 | 0.280 |
Why?
|
| Molecular Conformation | 2 | 2016 | 150 | 0.270 |
Why?
|
| Moths | 1 | 2023 | 9 | 0.240 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 237 | 0.230 |
Why?
|
| Aldehydes | 1 | 2023 | 65 | 0.230 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 58 | 0.230 |
Why?
|
| Hepatocytes | 1 | 2023 | 74 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 480 | 0.220 |
Why?
|
| Biological Factors | 1 | 2000 | 6 | 0.200 |
Why?
|
| Trees | 1 | 2000 | 19 | 0.190 |
Why?
|
| Quinolones | 1 | 2018 | 7 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2013 | 107 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 242 | 0.160 |
Why?
|
| Mice, Nude | 2 | 2016 | 323 | 0.160 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 64 | 0.150 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 27 | 0.150 |
Why?
|
| Tuberculosis | 1 | 2017 | 56 | 0.150 |
Why?
|
| Triazoles | 1 | 2017 | 85 | 0.150 |
Why?
|
| Iridoids | 1 | 2016 | 5 | 0.140 |
Why?
|
| Fermentation | 1 | 2016 | 25 | 0.140 |
Why?
|
| Histone Code | 1 | 2016 | 12 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 84 | 0.140 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2016 | 47 | 0.140 |
Why?
|
| Genetic Vectors | 1 | 2016 | 154 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 2 | 2016 | 92 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2016 | 118 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2016 | 121 | 0.130 |
Why?
|
| Hedera | 1 | 2014 | 1 | 0.130 |
Why?
|
| Zygophyllaceae | 1 | 2014 | 2 | 0.130 |
Why?
|
| Glioma | 1 | 2015 | 76 | 0.130 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2014 | 4 | 0.130 |
Why?
|
| Fruit | 1 | 2016 | 159 | 0.130 |
Why?
|
| Semaphorins | 1 | 2014 | 3 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2016 | 309 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 105 | 0.120 |
Why?
|
| Arabinonucleosides | 1 | 2014 | 2 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 649 | 0.120 |
Why?
|
| Hemolysis | 1 | 2014 | 39 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 63 | 0.120 |
Why?
|
| beta-Lactams | 1 | 2013 | 4 | 0.120 |
Why?
|
| Polycyclic Compounds | 1 | 2013 | 8 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 484 | 0.120 |
Why?
|
| Keratin-8 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 2128 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2014 | 77 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 195 | 0.120 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 129 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1149 | 0.120 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 49 | 0.110 |
Why?
|
| Hela Cells | 1 | 2014 | 344 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 152 | 0.110 |
Why?
|
| Flowers | 1 | 2012 | 16 | 0.110 |
Why?
|
| Rhamnose | 1 | 2011 | 2 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 91 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 756 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 781 | 0.100 |
Why?
|
| Yeasts | 1 | 2010 | 19 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 81 | 0.090 |
Why?
|
| Thiadiazoles | 1 | 2009 | 4 | 0.090 |
Why?
|
| Phenols | 1 | 2010 | 76 | 0.090 |
Why?
|
| Neoplasms | 2 | 2012 | 1033 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 901 | 0.090 |
Why?
|
| Plants | 2 | 2023 | 94 | 0.080 |
Why?
|
| Seawater | 1 | 2007 | 46 | 0.080 |
Why?
|
| Female | 4 | 2023 | 19873 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 109 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 1 | 2004 | 65 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2023 | 75 | 0.060 |
Why?
|
| Brucea | 1 | 2002 | 1 | 0.060 |
Why?
|
| Pyrans | 1 | 2002 | 9 | 0.060 |
Why?
|
| Seeds | 1 | 2002 | 34 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 83 | 0.050 |
Why?
|
| Thiocyanates | 1 | 1997 | 6 | 0.040 |
Why?
|
| Sulfoxides | 1 | 1997 | 16 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1997 | 48 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1997 | 21 | 0.040 |
Why?
|
| India | 1 | 1997 | 82 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1997 | 94 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2016 | 40 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2016 | 34 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 48 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 54 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.040 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Vimentin | 1 | 2015 | 32 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 84 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 177 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2014 | 20 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2015 | 167 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 351 | 0.030 |
Why?
|
| Methicillin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 52 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 171 | 0.030 |
Why?
|
| Catalysis | 1 | 2013 | 162 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 75 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 445 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 269 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 260 | 0.030 |
Why?
|
| Gold | 1 | 2013 | 134 | 0.030 |
Why?
|
| Base Sequence | 1 | 2013 | 932 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 90 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 834 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 122 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 160 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 396 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 878 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 4012 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 1802 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 99 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 11034 | 0.010 |
Why?
|
| Male | 1 | 2013 | 18870 | 0.010 |
Why?
|